Back to User profile » Dr Caicun Zhou
Papers published by Dr Caicun Zhou:
Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer
Sun C, Zhang L, Zhang W, Liu Y, Chen B, Zhao S, Li W, Wang L, Ye L, Jia K, Wang H, Wu C, He Y, Zhou C
OncoTargets and Therapy 2020, 13:6475-6483
Published Date: 3 July 2020
TIM-3, a promising target for cancer immunotherapy
He Y, Cao J, Zhao C, Li X, Zhou C, Hirsch FR
OncoTargets and Therapy 2018, 11:7005-7009
Published Date: 16 October 2018
sLAG-3 in non-small-cell lung cancer patients’ serum
He Y, Wang Y, Zhao S, Zhao C, Zhou C, Hirsch FR
OncoTargets and Therapy 2018, 11:4781-4784
Published Date: 13 August 2018
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC
He YY, Liu ST, Mattei J, Bunn Jr PA, Zhou CC, Chan D
Drug Design, Development and Therapy 2018, 12:981-986
Published Date: 24 April 2018
Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules
He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR
OncoTargets and Therapy 2017, 10:5915-5926
Published Date: 13 December 2017
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR
OncoTargets and Therapy 2016, 9:2409-2414
Published Date: 21 April 2016